These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11074252)

  • 1. C1q-binding peptides share sequence similarity with C4 and induce complement activation.
    Messmer BT; Thaler DS
    Mol Immunol; 2000 May; 37(7):343-50. PubMed ID: 11074252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential determination of ligands binding to discrete components in heterogeneous mixtures by iterative panning and blocking (IPAB).
    Messmer BT; Benham CJ; Thaler DS
    J Mol Biol; 2000 Feb; 296(3):821-32. PubMed ID: 10677284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterisation of C1q-binding phage displayed peptides.
    Lauvrak V; Brekke OH; Ihle O; Lindqvist BH
    Biol Chem; 1997 Dec; 378(12):1509-19. PubMed ID: 9461350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
    Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ
    J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.
    Gronemus JQ; Hair PS; Crawford KB; Nyalwidhe JO; Cunnion KM; Krishna NK
    Mol Immunol; 2010; 48(1-3):305-13. PubMed ID: 20728940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of the classical complement pathway by C1q-binding peptides.
    Roos A; Nauta AJ; Broers D; Faber-Krol MC; Trouw LA; Drijfhout JW; Daha MR
    J Immunol; 2001 Dec; 167(12):7052-9. PubMed ID: 11739526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions.
    Tacnet-Delorme P; Chevallier S; Arlaud GJ
    J Immunol; 2001 Dec; 167(11):6374-81. PubMed ID: 11714802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
    Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
    Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.
    Bergamaschini L; Canziani S; Bottasso B; Cugno M; Braidotti P; Agostoni A
    Clin Exp Immunol; 1999 Mar; 115(3):526-33. PubMed ID: 10193429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation by immunoglobulin does not depend solely on C1q binding.
    Bindon CI; Hale G; Waldmann H
    Eur J Immunol; 1990 Feb; 20(2):277-81. PubMed ID: 2311645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva.
    Su H; Boackle RJ
    Mol Immunol; 1991 Aug; 28(8):811-7. PubMed ID: 1875953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.
    Emmerling MR; Spiegel K; Watson MD
    Immunopharmacology; 1997 Dec; 38(1-2):101-9. PubMed ID: 9476121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain.
    Jiang H; Robey FA; Gewurz H
    J Exp Med; 1992 May; 175(5):1373-9. PubMed ID: 1569403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA binds and activates complement via residues 14-26 of the human C1q A chain.
    Jiang H; Cooper B; Robey FA; Gewurz H
    J Biol Chem; 1992 Dec; 267(35):25597-601. PubMed ID: 1460055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
    Inal JM; Schifferli JA
    J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
    Ying SC; Gewurz AT; Jiang H; Gewurz H
    J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
    Boackle RJ; Connor MH; Vesely J
    Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cells.
    Spear GT; Jiang HX; Sullivan BL; Gewurz H; Landay AL; Lint TF
    AIDS Res Hum Retroviruses; 1991 Jul; 7(7):579-85. PubMed ID: 1768460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins.
    Pasqualini R; Koivunen E; Ruoslahti E
    J Cell Biol; 1995 Sep; 130(5):1189-96. PubMed ID: 7657703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.